Q heads into its Q1 2026 earnings call on May 21 with a notable divergence: analysts lifted targets aggressively just days ago, yet the stock shed nearly 14% on the week.
The most striking angle heading into the print is the analyst pivot. RBC Capital raised its price target to $200 from $150 on May 13 — a 33% lift — while maintaining its Outperform rating. Mizuho followed the same day, bumping its target to $170 from $150. Both moves came after earlier rounds of upward revisions through February and April, building a consistent pattern of bullish re-rating. With the stock now at $145.24, RBC's $200 target implies roughly 38% upside. That gap between where analysts sit and where the stock closed after a brutal week is the central tension entering earnings.
Options traders have rotated decisively toward calls. The put/call ratio has tumbled to 0.31, well below its 20-day average of 0.39 and close to the lower end of its 52-week range. That's a crowd leaning heavily for upside, which is notable given the stock's sharp weekly decline — down 13.7% from last Friday's close. Bears may argue the stock ran too far too fast: shares are up 92.6% year-to-date on a PE of around 36x, and EV/EBITDA has compressed roughly 1.3 turns over the past week as the price corrected. Bulls counter that EPS momentum remains intact and the RSI of 61 is constructive without flashing overbought.
Short positioning tells a quiet story. The borrow market is essentially frictionless — availability is at the upper limit of the measurement scale, with cost to borrow at a trivial 0.30% and trending lower. Short interest has nudged up about 10% on the week in share terms, but the ORTEX short score of 29.8 is moderate, with no sign of a coordinated short build. Peers fared similarly or worse on the week: ENTG dropped 14.7%, ONTO fell 11.5%, and UCTT lost over 9%. The broader semiconductor equipment group was under pressure, suggesting macro or sector rotation rather than stock-specific deterioration.
One institutional signal worth noting: Durable Capital Partners added 2.3 million shares in Q1 2026 — a significant new build — while Allspring Global lifted its position by 3.9 million shares. That institutional accumulation ran concurrent with the analyst upgrade cycle. The earnings print tomorrow is therefore less about whether the growth narrative is intact and more about whether Q1 results and management guidance can justify the analyst community's rapidly rising targets against a stock that just gave back a month of gains in a single week.
See the live data behind this article on ORTEX.
Open Q on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
